OIMU
ELV icon

Osmosis Investment Management UK’s Elevance Health ELV Stock Holding History

Osmosis Investment Management UK’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.07M Sell
15,686
-4,624
-23% -$1.71M 0.28% 79
2026
Q1 		$5.95M Sell
20,310
-73,899
-78% -$24.3M 0.16% 131
2025
Q4 		$33M Buy
+94,209
New +$31.8M 0.83% 17

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Osmosis Investment Management UK's ELV Position: Q2 2026 in Review

Osmosis Investment Management UK reduced its Elevance Health (ELV) stake by 23% in Q2 2026, selling an estimated $1.71M and leaving 15,686 shares worth $6.07M. The position accounts for 0.28% of the portfolio, ranked #79.

Osmosis Investment Management UK first reported a position in ELV in Q4 2025 and has held it in 3 quarters since. The position peaked at $33M in Q4 2025. 1,604 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Osmosis Investment Management UK held 15,686 shares of Elevance Health worth $6.07M as of Q2 2026.
  • Osmosis Investment Management UK sold 4,624 Elevance Health shares in Q2 2026, an estimated $1.71M.
  • Elevance Health made up 0.28% of Osmosis Investment Management UK's portfolio in Q2 2026, its #79 holding.
  • Osmosis Investment Management UK first reported a position in Elevance Health in Q4 2025 and has held it in 3 quarters since.
  • Osmosis Investment Management UK's Elevance Health position peaked at $33M in Q4 2025.
  • 1,604 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Osmosis Investment Management UK's 13F filing for Q2 2026, filed 13 Aug 2026.